<DOC>
	<DOC>NCT01336153</DOC>
	<brief_summary>To investigate the safety and efficacy of MLC601 (NeuroAideTM) as a Traditional Chinese Medicine on motor recovery after ischemic stroke.</brief_summary>
	<brief_title>Clinical Study to Investigate the Safety and Efficacy of MLC601 in 150 Iranian Patients After Stroke</brief_title>
	<detailed_description>This is a double-blind, placebo-controlled clinical trial study on 150 patients with a recent (less than 3 month) ischemic stroke. All patients will give either MLC601 (100 patients) or placebo (50 patients), 4 capsules 3 times a day, as an add-on to standard medication of post stroke for 3 months. Motor improvement will be monitored using Fugl-Meyer Assessment FMA.</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<criteria>age between 3072 yars, &lt; one month after stroke, ischemic cerebral stroke, signed informed consent form. treatment with thrombolytic after stoke, ischemic stroke combined with hemorrhage, severe renal or liver failure, dementia, psychosis and history of seizure disorder, history of previous stroke, and hemoglobin level less than 10mg/dl on admission.</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>72 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>Safety</keyword>
	<keyword>Efficacy</keyword>
	<keyword>MLC601</keyword>
	<keyword>motor recovery</keyword>
</DOC>